JAM3 antibody (C-Term)
Quick Overview for JAM3 antibody (C-Term) (ABIN1882171)
Target
See all JAM3 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Binding Specificity
- AA 261-295, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This JAM3 antibody is generated from a rabbit immunized with a KLH conjugated synthetic peptide between 261-295 amino acids from the C-terminal region of human JAM3.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- WB: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Expiry Date
- 6 months
-
-
-
: "The junctional adhesion molecule 3 (JAM-3) on human platelets is a counterreceptor for the leukocyte integrin Mac-1." in: The Journal of experimental medicine, Vol. 196, Issue 5, pp. 679-91, (2002) (PubMed).
: "Narrowing the critical region within 11q24-qter for hypoplastic left heart and identification of a candidate gene, JAM3, expressed during cardiogenesis." in: Genomics, Vol. 79, Issue 4, pp. 475-8, (2002) (PubMed).
: "Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor." in: The Journal of biological chemistry, Vol. 276, Issue 49, pp. 45826-32, (2001) (PubMed).
-
-
- JAM3 (Junctional Adhesion Molecule 3 (JAM3))
-
Alternative Name
- JAM3
-
Background
- Participates in cell-cell adhesion. It is a counter- receptor for ITGAM, mediating leukocyte-platelet interactions and is involved in the regulation of transepithelial migration of polymorphonuclear neutrophils (PMN). The soluble form is a mediator of angiogenesis.
-
Molecular Weight
- 35020
-
UniProt
- Q9BX67
Target
-